NEW USES FOR OLDER DRUGS Dr Sanchit Gupta
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 1/21
NEW USES FOR OLDER DRUGS
Dr Sanchit Gupta
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 2/21
INTRODUCTION
Introducing a new drug to the market is a costly
affair.
The process may turn futile if it produces any
unacceptable adverse reaction or toxicity.
Discovering new uses for the already-existingdrugs with known adverse drug reaction profile
may prove to be beneficial.
Most of these novel uses are based on the off-label use of the drugs.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 3/21
Off-label use entails the use of drugs: For unapproved clinical indications (e.g.,
Bupropion for smoking cessation).
In unapproved age group (e.g.,
dextroamphetamine for adult ADHD treatment).
Off-label use is widespread and it is legal inthe US accounting for 21% of outpatientprescription.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 4/21
Primary pharmacological actions of aspirin are
analgesic, antiinflammatory and antipyretic. (Beaver,
1965)
Also inhibit platelet aggregation.
In 1988, US-FDA proposed using aspirin toreduce the risk of recurrent myocardial
infarction and to prevent recurrent transientstrokes in men.
ASPIRIN
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 5/21
Aspirin has been shown to be effective in reducing
cardiovascular morbidity and mortality in high-riskpatients with myocardial infarction (MI) or stroke(secondary prevention). (Baigent et al, 2009)
Also recommended for prevention of CVD in
diabetics at high risk. (Buse et al, 2007; Pignone et al, 2010)
Other uses explored for aspirin include theprevention of colon cancer, esophageal cancer, andother diseases. (Sirven, 2010)
ASPIRIN cont’d
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 6/21
Beta-blockers in malaria
World wide, there has been a resurgence ofmalaria in recent years, mainly due to the
parasite's growing resistance to drugs.
G-proteins in the red blood cell were shown to
be used by the parasite to enter the red bloodcells.
Two major Gs-associated receptors, the beta-
adrenergic and the adenosine receptors, areknown to be present in red blood cells
The use of beta-receptor antagonists may
provide new approaches for treating malaria.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 7/21
Gabapentin for pain
Gabapentin was developed as an anticonvulsant.
It has no direct GABAergic action.
In 2002, an indication was added for the
treatment of neuropathic pains. The mechanism of action is not clearly
understood
it is thought to exert its clinical effect by
selective binding of the α2δ subunit of voltage-dependent calcium channels. (Gee et al , 1996)
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 8/21
Magnesium sulphate for
asthma and tocolysis Magnesium sulphate, blocks calcium-mediated
smooth-muscle contraction, resulting inbronchodilatation.
It was suggested that it binds competitively withcalcium-storage sites in the endoplasmic reticulumand thereby uncouples the activation of actin-myosin unit.
Intravenous magnesium sulphate therapy may be
considered in patients with severe asthmaexacerbation.
Tocolysis may be another potential use ofmagnesium.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 9/21
Methotrexate (MTX)
MTX was first introduced as an anticancer drug,but since the 1960s it has been used to treat
psoriasis and other skin conditions.
Low dose MTX, an antiinflammatory drug, is a
well-established medication for rheumatoid
arthritis and psoriasis.
low-dose methotrexate has also emerged as a
new therapy for chronically active Crohn disease.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 10/21
Octreotide for dumping
syndrome In the past decade, it has been suggested that
octreotide an analogue of stomatostatin, canalleviate dumping.
In particular, it has been demonstrated to beeffective in patients refractory to standardtherapy.
Administration of octreotide 30 min before,or immediately after a meal offers a practicaland effective approach to the treatment ofearly and late dumping syndrome.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 11/21
Paclitaxel for preventing
restenosis The taxanes are potent antiproliferative
agents used in cancer chemotherapy.
They promote polymerization of the alphaand beta subunits of tubulin and therebystabilizes the microtubules.
In randomized controlled trials, stents coatedwith paclitaxel has been found to significantlyreduce the restenosis rates after coronaryangioplasty.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 12/21
Thalidomide (α-N-[phthalimido] glutarimide) was first synthesized in 1953 by Ciba. (Rajkumar, 2004)
Was introduced into the market in 1957 as a non-addictive, relatively “risk-free” sedative and fortreating morning sickness. (James, 1993; Sirven, 2010)
Was taken off market in 1961 because of itspotent teratogenicity. (Lenz, 1988; 1992)
THALIDOMIDE
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 13/21
Has R- and S- enantiomers
R- enantiomer ----- sedative activities
S- enantiomer ----- teratogenic and antitumor properties. (Stirling, 2000; Eriksson et al , 2001)
It was later re-introduced as treatment for:
Erythema nodosum leprosum [ENL]. (Iyer et al,
1971)
Oral ulcer and wasting associated with HIV.(Youle et al, 1989; Reyes-Teran, 1996)
THALIDOMIDE cont’d
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 14/21
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 15/21
Other promising uses still under investigationinclude:
Kaposi sarcoma (Little et al , 2000)
Renal cell carcinoma (Minor et al, 2002; Motzer et al, 2002) Reflex sympathetic dystrophy syndrome
(Rajkumar, 2004)
Inflammatory bowel disease. (Sirven, 2010)
THALIDOMIDE cont’d
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 16/21
Mechanism of action is still unclear Inhibition of TNF-α. (Sampaio et al, 1991; Moreira et al, 1993)
Promotion of the activity of T cells and natural killercells.
Inhibition of the release of cytokines. (Hideshima et al,2001; Mitsiades et al, 2002)
Toxicity – peripheral neuropathy, constipation,sedation, deep venous thrombosis,hypothyroidism. (Rajkumar et al, 2000; Osman et al, 2001;
Zangari et al, 2002; Ghobrial & Rajkuymar, 2003)
THALIDOMIDE cont’d
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 17/21
Zileuton for acne and RSV
Among the several diseases, hyperkeratoticinflammatory skin disorders especially psoriasisseem to respond to LTB4 inhibitors.
Recently potential involvement of arachidonic
acid pathway has been documented in thedevelopment of acne and provides logicalsupport for use of LTB4 inhibitors in acnetreatment.
Its role is also coming up in the treatment ofairway obstruction after respiratory syncytialvirus (RSV) infection.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 18/21
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 19/21
Conclusion
Although a large number of old drugs with newpotential uses have been discussed here, still the listcannot be claimed to be complete.
With advancement in our knowledge we can makeuse of these time-tested drugs in diverse areas of
clinical practice. However, unethical promotion of the irrational use
of drugs for economic benefits by thepharmaceutical companies needs to be curbed.
Neverthless, these initial findings discussed hereneed to be pursued by more researches so that thepotential benefits could be passed on to thepatients.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 20/21
References 1.Pharma Times News [homepage on the Internet]. Drug development tops
$897 million. [cited 2003 May 15]. Available from:http://www.ptwebcast.com
2.Ravot E, Lisziewicz J, Lori F. New uses for old drugs in HIV infection: therole of hydroxyurea, cyclosporin and thalidomide. Drugs 1999;58:953-63.
3.Kimberly J, La Pointe. Childrens Hospital of the Kings' Daughters Norfolk,
Virginia, USA. Available from:http://www.dekker.com/servlet/product/DOI/101081EECP120006328/authors/?t=a#0.
4.Esposito S. Off-label prescribing of drugs call FDA role into question.Medical Sentinel 2002;7:24.
5.Newbold BB. How medicines are discovered? In: Burley DM, Clarke JM,Lasagna L, editors. Pharmaceutical Medicine. 2nd ed. London: Pub. EdwardArnold; 1993. p. 1-11.
6.Stitzel RE, McPhillips JJ. Transitions and progress in therapeutics. In: CraigCR, Stitzel RE, editors. Modern Pharmacology with Clinical Applications. 5thed. New York: Pub. Little, Brown and Company (Inc.); 1997. p. 85-91.
8/12/2019 New Uses for Older Drugs
http://slidepdf.com/reader/full/new-uses-for-older-drugs 21/21
THANK YOU